[ad_1]
Jakarta, CNBC Indonesia – A Covid-19 detection tool from the experts at Gadjah Mada University (UGM) called GeNose finally has a distribution permit and is ready for mass commercialization.
The head of the GeNose development team, Prof. Kuwat Triyana, said that the GeNose distribution permit from the Ministry of Health was issued on Thursday (12/24/2020). The permit was issued after his party submitted a presentation to health authorities.
“Alhamdulillah, thanks to prayers and extraordinary support from many parties, GeNose C19 has officially obtained a distribution permit to begin receiving recognition from regulators, namely the Ministry of Health, to assist in the management of Covid- 19 through rapid detection, “it said in a written statement on Saturday (12/26/2020).
Once the distribution permit is obtained, the team will deliver the first mass production batch of GeNose C19, which is funded by BIN and Kemenristek / National Agency for distribution.
They hope the limited number of GeNose C19 will give maximum impact. “With 100 units of the first batch to be released, we expect to conduct 120 tests per device or a total of 12,000 people a day,” he said.
“The figure of 120 tests per device is based on the estimate that each test takes 3 minutes including taking a breath so that one hour can test 20 people and if it is effective the tool works for 6 hours,” he explained.
Next page >> Price IDR 25,000
